Browsing: China

Add preferred source On November 1, several Chinese EV startups reported October 2026 delivery figures. Leapmotor delivered 106,127 vehicles, marking its fourth consecutive month above 100,000 units. XPeng Group delivered 50,237 vehicles and Xiaomi Auto delivered more than 50,000, both crossing the 50,000 threshold for the first time. NIO delivered 34,246 vehicles and Li Auto…

Apple will integrate Alibaba Group’s Qwen artificial intelligence models into Apple Intelligence in China, bringing the United States technology giant’s long-awaited AI services to Chinese iPhone users.

For countries facing shrinking populations, improving productivity may matter as much as increasing birth rates, say these academics.

Exclusive in English — 27 октября 2026 18:00 0

Nvidia (NasdaqGS:NVDA) has effectively lost its China AI accelerator market after U.S. export controls restricted advanced GPU shipments.

Russia has been selling off gold throughout this year. September brought a further reduction in its reserves of the precious metal of around 6.2 tonnes, bringing the total reduction since January to about 62 tonnes.

BUSINESS / ECONOMY China condemns US proposed rules expanding American investment curbs The Ministry of Commerce of China File photo: VCG

With the two leading AI powers, the United States and China, forming their own AI blocs, other countries are maneuvering to harness the strengths of both groupings and avoid losing out

Add preferred source At the 2026 Third “Tech-Industry-Finance Coordinated Development Forum,” Tu Guangshao, former Standing Committee member of the Shanghai Municipal Party Committee and former Executive Vice Mayor of the Shanghai Municipal Government, argued that China does not lack funds—what it lacks is tech capital capable of bearing risk, investing for the long term, and…

Add preferred source Treasury’s proposed COINS outbound-investment rules add biotech to the sectors restricted from Chinese investment, but the text never mentions licensing — the deal structure that has driven biopharma M&A for two years. The risk hides in two other clauses: a “joint venture” defined only by its plain-English meaning, and a prohibited-technology list…